Company intelligence / Profile preview
Hexima
Melbourne, Victoria, Australiahexima.com.au ↗
- Ownership
- Public · HXL
- Development stage
- Other
01
Overview
Hexima Limited develops plant-derived proteins and peptides as human antifungal therapeutics. The company has advanced to clinical-stage development, but specific clinical trial results are not detailed in the available sources.
- Therapeutic areas
- Infectious Diseases
- Modalities
- ProteinPeptidesBiologic
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Hexima.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hexima.